Nasdaq
HALO
Halozyme Therapeutics, Inc.
- Health Care
- 1 day
- +2.6%
- 1 month
- +5.1%
- 1 year
- +37.6%
$85.76 · Mkt cap $10.2B · P/E 33.5
At the 6 Aug 2026 close
Nasdaq
Halozyme Therapeutics, Inc.
$85.76 · Mkt cap $10.2B · P/E 33.5
At the 6 Aug 2026 close
Halozyme Therapeutics, Inc. trades under the ticker HALO on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). Its market capitalisation is $10.2B. The last closing price was $85.76, on 6 Aug 2026. It trades at 33.5 times its last reported annual diluted earnings per share. Over the past year the share price is +37.6%, and +5.1% over the past month. Returns are price returns and exclude dividends.
This page exists because HALO is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.